Intimation regarding the completion of acquisition of 74% of equity shares in DBION Private Limited.
M&A
▲ Positive Development
LOW RISK
📅 Filed on BSE: 09 Jul 2026, 09:22 PM IST · BSE ID: 73eaa8bb-12f0-4cdb-b3b9-1023024583ff
View Original BSE Filing (PDF)
💡
In Simple Terms
The company bought 74% of DBION Private Limited for Rs. 74,000, making it a subsidiary.
🤖 AI Summary
- Dhampur Bio Organics Ltd completed acquisition of 74% equity shares in DBION Private Limited.
- The acquisition involved 7400 equity shares at Rs. 10 each, totaling Rs. 74,000.
- DBION Private Limited is now a subsidiary and a Joint Venture Company of Dhampur Bio Organics.
- The acquisition aligns with a Joint Venture Agreement with Orgonew Private Limited.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity shares acquired
7400
Acquisition cost per share
Rs. 10
Total acquisition amount
Rs. 74,000
Percentage of equity acquired
74%
🏢 How This Affects the Company
The acquisition expands Dhampur Bio Organics' business scope by incorporating DBION Private Limited, formerly Sonitron Chemicals Private Limited, as a subsidiary and joint venture.
Dhampur Bio Organics deployed Rs. 74,000 for this acquisition, directly impacting its cash position and increasing its asset base through the new subsidiary.
DBION Private Limited's operations are now integrated into Dhampur Bio Organics' structure as a subsidiary, potentially affecting overall operational synergies.
The integration of DBION Private Limited as a subsidiary may introduce new operational or market-related risks associated with its specific business activities.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
Shareholders of Dhampur Bio Organics Ltd are affected as the company's structure now includes DBION Private Limited as a 74% owned subsidiary.
🔍
Management Signal
Management is actively pursuing inorganic growth and strategic partnerships, as evidenced by the completion of this acquisition and adherence to a Joint Venture Agreement.
For information only. Not investment advice. ForgeUp is not SEBI-registered.
👁 Watch List — track these upcoming events
Dhampur Bio Organics' next quarterly results — look for details on DBION's contribution.
Future announcements regarding DBION Private Limited's business operations or results.
Updates on the Joint Venture Agreement with Orgonew Private Limited.
LOW RISK
The filing reports the completion of a small-scale acquisition with minimal financial outflow (Rs. 74,000).
💡 Investor Takeaway
Dhampur Bio Organics Ltd has completed the acquisition of 74% of equity shares in DBION Private Limited (formerly Sonitron Chemicals Private Limited) for Rs. 74,000. This confirms DBION Private Limited as a subsidiary and Joint Venture Company.
⚖️ Strengths & Concerns
✅ Positives
- Completion of the acquisition solidifies Dhampur Bio Organics' control with 74% equity in DBION Private Limited.
- The acquisition formalizes DBION Private Limited as both a subsidiary and a Joint Venture Company, aligning with strategic agreements.
⚠️ Concerns
- No financial details beyond the acquisition value of Rs. 74,000 were provided for DBION Private Limited's operations.
- The filing does not detail the specific business activities of DBION Private Limited or its contribution to revenue.
❓ Frequently Asked Questions
What percentage of DBION Private Limited did Dhampur Bio Organics acquire?
Dhampur Bio Organics Ltd acquired 74% of the paid-up equity share capital in DBION Private Limited.
What was the total cost of acquiring DBION Private Limited?
The Company acquired 7400 equity shares at Rs. 10 each, amounting to a total cost of Rs. 74,000.
What is the new status of DBION Private Limited after the acquisition?
Consequent to this acquisition, DBION Private Limited is now a subsidiary of Dhampur Bio Organics Ltd and a Joint Venture Company under the Joint Venture Agreement.
When was the completion of the DBION Private Limited acquisition announced?
The completion of the acquisition was intimated on July 09, 2026, following earlier Board Meetings on April 20, 2026, and May 30, 2026.
Questions based on this BSE filing only. For information purposes.